Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized High Dose Methotrexate for the Treatment of Malignancies in Children and Adolescents With a Significant Risk for Methotrexate Toxicities

NCT02076997 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02076997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02076997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized High Dose Methotrexate for the Treatment of Malignancies in Children and Adolescents With a Significant Risk for Methotrexate Toxicities
Lead sponsor
Baylor College of Medicine
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2014
Completion date
May 10, 2019
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer